查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014874

退伍軍人菌檢測市場：2026-2032年全球市場預測（依產品類型、檢測方法、應用、最終用戶及通路分類）

Legionella Testing Market by Product Type, Test Method, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，退伍軍人菌檢測市場價值將達到 4.2131 億美元，到 2026 年將成長至 4.6308 億美元，到 2032 年將達到 7.8864 億美元，複合年成長率為 9.36%。

主要市場統計數據
基準年 2025 4.2131億美元
預計年份：2026年 4.6308億美元
預測年份 2032 7.8864億美元
複合年成長率 (%) 9.36%

本執行摘要概述了影響退伍軍人菌檢測和控制趨勢的關鍵發展。儘管公共衛生部門和設施管理人員長期以來一直將退伍軍人菌監測放在優先位置，但近期的技術進步、監管力度的加強以及不斷變化的運營要求正在重塑各組織檢測和降低風險的方式。實驗室科學、設施營運、供水事業和商業房地產領域的相關人員越來越需要能夠將檢查室結果與現場實施相結合的實用見解。

本文重點闡述了調查方法、供應鏈趨勢、監管壓力和終端用戶期望最顯著的變化。文章分析了價格調整的影響，檢驗了測試方法、產品類型、應用領域、終端用戶和分銷管道等方面的細分差異，並提供了區域觀點以輔助策略規劃。文章始終關注如何將測試數據轉化為穩健的管理方案，增強採購韌性，並利用創新來加快結果獲取速度，提高決策信心。

本導言為後續章節奠定了基礎，後續章節將提供深入的分析和切實可行的建議。其目的是為領導者提供與實際情況相關的觀點，以支援投資決策、供應商合作以及實驗室和現場工作流程的改進。

診斷技術的快速發展、更嚴格的監管以及不斷變化的供應鏈如何重塑檢測實踐、採購和營運整合。

過去幾年，一系列變革性的變化重新定義了退伍軍人菌檢測的概念、實施和執行方式。分子診斷和生物感測器平台的技術進步縮短了反應時間，並將檢測施行地點從中心檢查室擴展到了現場適用的模式。同時，濃縮檢體技術、自動化系統和試劑品質的改進提高了檢測的重複性，減少了人為誤差，並使監測方案更加一致。

評估 2025 年關稅變化將如何影響整個退伍軍人菌檢測生態系統的供應鏈、籌資策略和成本管理實務。

美國2025年實施的關稅政策正在對整個退伍軍人菌檢測生態系統產生複雜的連鎖反應，影響製造商、經銷商、檢測實驗室和最終用戶。對於依賴全球採購精密零件的設備製造商而言，進口成本的增加促使他們重新評估供應鏈策略以降低關稅風險。這包括遷移組裝基地、實現供應商多元化以及重新設計產品，更加重視模組化。這些策略調整正在影響檢查室管理人員和設施營運者的前置作業時間、產品供應以及長期資本規劃。

從綜合角度進行觀點，將分析方法、產品系列、應用、最終用戶和通路與業務需求相匹配。

了解市場區隔對於設計滿足營運需求和監管要求的檢測策略至關重要。在考慮檢測方法時，相關人員必須仔細權衡生物感測器平台、培養方法、免疫檢測和聚合酵素鏈鎖反應(PCR) 技術之間的利弊，每種方法都有其獨特的操作特性。培養方法通常是符合監管要求的基礎，包括薄膜過濾和傳統瓊脂培養，每種方法的樣本處理和菌落計數流程各不相同。免疫檢測分析，例如酵素連結免疫吸附試驗 (ELISA) 和橫向流動化驗，可提供快速篩檢能力，適用於高頻監測。同時，聚合酵素鏈鎖反應(PCR) 方法，包括即時PCR和常規 PCR，可提供高靈敏度的分子檢測，儘管它們對儀器和結果解讀的要求各不相同。生物感測器技術因其速度和易用性而備受關注，尤其是在現場監測領域。

影響全球市場退伍軍人菌監測計畫技術部署、服務模式和擴充性的區域趨勢和監管差異。

區域趨勢顯著影響著檢測專案的架構、技術的優先順序以及服務模式的演進。在美洲，監管審查和公司治理標準的提高推動了對檢驗的快速檢測方法、整合資料平台以及跨多站點組合的可擴展服務夥伴關係的需求。該地區的市場參與企業通常優先考慮與建築管理系統的互通性以及集中式報告，以支援企業範圍內的風險監控。

競爭洞察表明，創新、品質系統和服務的整合如何決定市場定位和市場接受度。

退伍軍人菌檢測領域的競爭動態由技術創新、服務差異化和供應鏈韌性三者共同塑造。領先的製造商持續投資於快速分子檢測、自動化和整合分析，而專業服務商則專注於現場生物感測器和高度自動化培養工作站等特色功能。檢測開發人員、儀器製造商和服務實驗室之間的策略夥伴關係日益普遍，從而能夠提供包含硬體、耗材、驗證支援和資料管理的捆綁式服務。

檢查室經理、採購團隊和設施經理可以實施的可操作的策略和營運措施，以提高檢測的有效性和韌性。

產業領導者應採取多管齊下的策略，在投資快速診斷的同時，兼顧嚴格的驗證和採購的靈活性。優先進行將測試性能與營運決策標準直接掛鉤的驗證研究，確保所選方法適用於設施內遇到的特定檢體基質和應用場景。除實驗室驗證外，還應進行現場初步試驗，評估易用性、維護要求和下游資料整合要求。

結合相關人員訪談、實驗室檢驗審查和供應鏈映射的穩健混合研究途徑，得出了切實可行的建議。

本研究採用混合方法，旨在同時捕捉技術性能特徵和實際運作情況。初步調查包括對相關人員進行結構化訪談，這些利害關係人包括實驗室經理、設施經理、供水事業代表和監管機構，以收集有關方法選擇標準、採購限制和檢驗期望的定性見解。除了這些相關人員的觀點外，還對檢查室工作流程和現場採樣程序進行了觀察性審查，以使結論與實際應用情境相符。

關鍵發現的整合突顯了嚴謹的調查方法、採購韌性和營運整合如何將診斷與有效的風險降低聯繫起來。

總而言之，退伍軍人菌檢測生態系統正處於技術能力、監管預期和採購現實交匯的十字路口。分子診斷和生物感測器平台的進步提供了更快、更靈活的檢測方法，但其價值取決於嚴格的檢驗、營運整合和可靠的供應鏈。關稅波動凸顯了供應商透明度和國內韌性的重要性，影響籌資策略，並促使各組織重新評估其庫存和採購政策。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：退伍軍人菌檢測市場：依產品類型分類

  • 裝置
    • 自動化系統
    • 手動系統
  • 成套工具
  • 試劑和耗材
    • 抗體
    • 培養基
    • DNA聚合酵素
  • 服務

第9章退伍軍人菌檢測市場及檢測方法

  • 生物感測器
  • 培養方法
    • 薄膜過濾培養
    • 傳統瓊脂培養法
  • 免疫檢測
    • ELISA
    • 橫向流動化驗
  • 聚合酵素鏈鎖反應
    • 即時PCR
    • 常規PCR

第10章：退伍軍人菌偵測市場：依應用領域分類

  • 環境監測
  • 設施管理
  • 水處理

第11章退伍軍人菌檢測市場：依最終用戶分類

  • 商業建築
  • 醫院
  • 研究機構
  • 供水事業

第12章退伍軍人菌檢測市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上

第13章退伍軍人菌檢測市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章退伍軍人菌檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章退伍軍人菌檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國退伍軍人菌檢測市場

第17章：中國退伍軍人菌檢測市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Aquacert Ltd.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Eurofins Scientific SE
  • Hologic, Inc.
  • Hydrosense Ltd.
  • IDEXX Laboratories, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Neogen Corporation
  • PerkinElmer, Inc.
  • Pro-Lab Diagnostics, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Roche Diagnostics
  • Spartan Bioscience Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-43470FC6086E

The Legionella Testing Market was valued at USD 421.31 million in 2025 and is projected to grow to USD 463.08 million in 2026, with a CAGR of 9.36%, reaching USD 788.64 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 421.31 million
Estimated Year [2026] USD 463.08 million
Forecast Year [2032] USD 788.64 million
CAGR (%) 9.36%

This executive summary synthesizes the critical developments shaping the landscape of Legionella testing and control. While public health authorities and facility managers have long prioritized Legionella surveillance, recent technological advances, heightened regulatory scrutiny, and evolving operational demands are converging to reshape how organizations detect and mitigate risk. Stakeholders across laboratory science, facility operations, water utilities, and commercial real estate increasingly require actionable intelligence that bridges laboratory performance with on-the-ground implementation.

The narrative that follows distills the most salient shifts in methodologies, supply chain dynamics, regulatory pressure points, and end-user expectations. It highlights the implications of tariff adjustments, examines segmentation nuances across test methods, product types, applications, end users, and distribution channels, and provides regional perspectives to inform strategic planning. Throughout, emphasis is placed on operationalizing test data into robust control programs, strengthening procurement resilience, and leveraging innovation to reduce time-to-result and enhance confidence in decision-making.

This introduction frames the subsequent sections, which collectively deliver both analytic depth and pragmatic recommendations. The intent is to equip leaders with context-rich perspectives that support investment decisions, supplier engagement, and improvements to laboratory and field workflows.

How rapid diagnostic advances, regulatory tightening, and supply chain evolution are collectively reshaping testing practices, procurement, and operational integration

The past several years have witnessed a set of transformative shifts that are redefining how Legionella testing is conceived, executed, and translated into action. Technological progress in molecular diagnostics and biosensor platforms has compressed time-to-result and expanded the locus of testing beyond centralized laboratories into field-adaptable formats. Concurrently, improvements in sample concentration, automated systems, and reagent quality are enhancing reproducibility and reducing manual variability, enabling more consistent surveillance programs.

Regulatory frameworks are tightening in many jurisdictions, prompting greater documentation, standardized validation, and expectations for traceability. This regulatory tightening operates alongside growing stakeholder demand for transparency in water management, driving facility managers and water utilities to integrate testing outputs with building automation and risk management dashboards. At the same time, supply chain complexity and the emergence of novel service models, such as turnkey monitoring subscriptions and third-party laboratory partnerships, are altering procurement behavior and vendor relationships.

Taken together, these shifts are creating a landscape where speed, reliability, and interoperability matter as much as analytical sensitivity. Leaders who align investments in new technology with robust validation protocols and clear operational pathways will be better positioned to convert diagnostic advances into measurable reductions in exposure risk.

Assessment of how tariff changes in 2025 have altered supply chains, procurement strategies, and cost-management approaches across the Legionella testing ecosystem

The introduction of tariffs in the United States during 2025 has generated a complex ripple effect across the Legionella testing ecosystem, affecting manufacturers, distributors, laboratories, and end users. For equipment makers that rely on global sourcing for precision components, increased import costs have incentivized a reassessment of supply chain strategies, including relocation of assembly, diversification of suppliers, and redesigns that emphasize modularity to mitigate tariff exposure. These strategic adjustments carry implications for lead times, product availability, and long-term capital planning for laboratory managers and facility operators.

Reagents and consumables, which often represent recurring expenditure for testing programs, are particularly sensitive to cost shifts. Laboratory directors and procurement teams are therefore reassessing inventory policies, evaluating alternative reagent chemistries, and negotiating longer-term supply agreements to stabilize unit costs. In parallel, service providers and contract laboratories face decisions about absorbing costs, passing them through to clients, or optimizing workflows to preserve margins while maintaining turnaround times and quality standards.

Importantly, tariff-induced pressures are accelerating two broader responses. First, there is a renewed emphasis on domestic manufacturing and local supplier development to reduce exposure to cross-border policy volatility. Second, organizations are increasingly valuing supplier transparency and resilience as procurement criteria, prioritizing partners that can offer validated equivalence across reagent lots, local technical support, and contingency plans for component shortages. These shifts are reshaping competitive dynamics and complicating procurement decisions for entities responsible for Legionella surveillance.

Comprehensive segmentation perspectives that align analytical methods, product portfolios, applications, end users, and distribution pathways with operational needs

Understanding market segmentation is central to designing testing strategies that match operational needs and regulatory expectations. When considering test methods, stakeholders must weigh trade-offs among biosensor platforms, culture methods, immunoassays, and polymerase chain reaction techniques, each offering distinct operational profiles. Culture methods remain foundational for regulatory compliance in many contexts and include both membrane filtration culture and traditional agar culture approaches that differ in sample processing and colony enumeration workflows. Immunoassay tools such as ELISA and lateral flow assays offer rapid screening capabilities that can be useful for high-frequency monitoring, whereas polymerase chain reaction approaches, which encompass real-time PCR and traditional PCR, provide sensitive molecular detection with varying requirements for instrumentation and interpretation. Biosensor technologies are gaining traction for on-site monitoring where speed and ease of use are prioritized.

Product type influences procurement and laboratory design. Equipment choices span automated and manual systems, with automation delivering throughput and consistency while manual systems provide cost flexibility for low-volume operations. Kits, reagents, and consumables form the backbone of daily testing activity; key reagent categories include antibodies, culture media, and DNA polymerases, all of which must meet rigorous quality and lot-to-lot consistency standards. Services-ranging from third-party laboratory analysis to managed monitoring programs-offer alternative pathways for entities that prefer to outsource technical execution and focus on corrective actions.

Applications for Legionella testing vary by context and are commonly grouped into environmental monitoring, facility management, and water treatment. Each application carries unique sample matrices, result-use cases, and risk tolerances, necessitating method selection and validation strategies tailored to the specific purpose. End users include commercial buildings, hospitals, research institutes, and water utilities, with each category presenting distinctive operational constraints, compliance obligations, and stakeholder expectations. Distribution channel choices-direct sales, distributors, and online-shape access to products and support services, affecting lead times, technical service availability, and procurement complexity. Integrating these segmentation dimensions enables targeted procurement, optimized workflows, and stronger alignment between analytical capability and on-site risk mitigation.

Regional dynamics and regulatory variations that influence technology adoption, service models, and the scalability of Legionella monitoring programs across global markets

Regional dynamics exert a strong influence on how testing programs are structured, which technologies are prioritized, and how service models evolve. In the Americas, regulatory attention and corporate governance standards are driving demand for validated rapid methods, integrated data platforms, and service partnerships that can scale across multi-site portfolios. Market participants in this region often emphasize interoperability with building management systems and centralized reporting to support enterprise-wide risk oversight.

Europe, the Middle East & Africa present a heterogeneous regulatory and infrastructural environment where adoption patterns vary across jurisdictions. Some countries implement stringent water safety plans and prescriptive testing protocols, while others emphasize capacity building and advisory frameworks. This diversity creates opportunities for technology providers that can offer modular solutions adaptable to both highly regulated hospital settings and broader municipal water systems. The region also demonstrates active interest in sustainability and resource efficiency, which influences sampling strategies and equipment selection.

Asia-Pacific features rapid infrastructure development, a rising focus on public health resilience, and growing investment in laboratory modernization. Water utilities and large commercial developers in the region are increasingly adopting automated systems and molecular diagnostics to meet tightening standards and customer expectations. Across all regions, local manufacturing capability, regulatory alignment, and access to technical service networks remain critical determinants of method adoption and the feasibility of scaling monitoring programs.

Insights into competitive dynamics showing how innovation, quality systems, and service integration determine market positioning and adoption trajectories

Competitive dynamics in the Legionella testing space are shaped by a combination of technological innovation, service differentiation, and supply chain resilience. Leading manufacturers continue to invest in rapid molecular assays, automation, and integrated analytics, while specialized providers focus on niche capabilities such as on-site biosensors or highly automated culture workstations. Strategic partnerships between assay developers, instrument manufacturers, and service laboratories are increasingly common, enabling bundled offerings that combine hardware, consumables, validation support, and data management.

Moreover, companies that demonstrate robust quality management systems and transparent lot validation processes gain trust among laboratory directors and facility managers. Service-oriented firms differentiate through flexible contracting models, managed monitoring programs, and the ability to rapidly scale field operations for multi-site clients. From a commercial perspective, distribution strategies that combine direct engagement with channel partners and digital commerce facilitate faster deployment and localized support.

Intellectual property around assay chemistries and biosensor architectures continues to influence competitive positioning, and investments in regulatory submissions and field validation studies remain key barriers to entry. Firms that align R&D with pragmatic user needs-streamlined workflows, minimal training requirements, and clear interpretive guidance-are best positioned to win adoption among both centralized laboratories and decentralized facility teams. Ultimately, the market rewards combinations of technical excellence, operational support, and resilient supply chains.

Actionable strategic and operational measures that laboratory managers, procurement teams, and facility leaders can implement to enhance testing effectiveness and resilience

Industry leaders should adopt a multi-pronged strategy that balances investment in rapid diagnostics with rigorous validation and procurement resilience. First, prioritize validation studies that directly map test performance to operational decision thresholds, ensuring that chosen methods are fit-for-purpose across the specific sample matrices and use-case scenarios encountered in your facilities. Complement laboratory validation with field pilots that assess ease of use, maintenance demands, and downstream data integration requirements.

Second, strengthen supplier relationships by incorporating resilience criteria into procurement processes. Require transparency on reagent equivalence, alternate sourcing plans, and local technical support. Where feasible, diversify supplier portfolios to reduce exposure to single-source disruptions and evaluate long-term contracting to manage price volatility associated with policy shifts. Third, invest in workforce capability and procedural standardization so that test outputs reliably translate into corrective actions. Training programs, competency assessments, and clear escalation pathways will reduce interpretation variability and improve response times.

Finally, integrate testing outputs into broader water safety and facility management systems to turn data into preventive measures. Establish clear governance for data ownership, thresholds that trigger remediation, and periodic review processes that incorporate new scientific evidence and regulatory updates. By combining technical rigor with supply chain foresight and operational integration, organizations can enhance resilience and more effectively mitigate Legionella exposure risk.

Robust mixed-methods research approach combining stakeholder interviews, laboratory validation reviews, and supply chain mapping to inform pragmatic recommendations

The underlying research employs a mixed-methods approach designed to capture both technical performance attributes and operational realities. Primary research included structured interviews with laboratory directors, facility managers, water utility representatives, and regulatory stakeholders to gather qualitative insights on method preferences, procurement constraints, and validation expectations. These stakeholder perspectives were supplemented by observational reviews of laboratory workflows and field sampling protocols to ground conclusions in real-world practices.

Secondary research drew on peer-reviewed literature, regulatory guidance documents, and technical white papers to map method capabilities, performance characteristics, and compliance drivers. Laboratory verification studies were reviewed to evaluate comparative time-to-result, sensitivity, and operational requirements across culture, immunoassay, molecular, and biosensor approaches. Supply chain analyses assessed component sourcing pathways, distributor networks, and service model configurations to identify resilience factors and potential bottlenecks.

Analytic steps included cross-validation of qualitative findings with technical performance summaries and supply chain mapping, followed by synthesis into actionable recommendations. Where relevant, scenario analyses explored implications of procurement disruptions and regulatory shifts to inform strategic options without producing numeric forecasts. This methodology ensures that the findings reflect both the scientific realities of assay performance and the pragmatic constraints of implementation in diverse operational contexts.

Synthesis of key findings emphasizing how methodological rigor, procurement resilience, and operational integration translate diagnostics into effective exposure mitigation

In sum, the Legionella testing ecosystem is at an inflection point where technological capability, regulatory expectations, and procurement realities intersect. Advances in molecular diagnostics and biosensor platforms are delivering faster and more flexible options for detection, but their value hinges on rigorous validation, operational integration, and reliable supply chains. Tariff-related shifts have underscored the importance of supplier transparency and domestic resilience, influencing procurement strategies and prompting organizations to reassess inventory and sourcing policies.

Segmentation analysis clarifies that method selection must be purpose-driven: culture-based approaches remain central to many compliance frameworks, immunoassays and biosensors provide rapid screening capacity, and PCR techniques offer molecular sensitivity suited to specific investigative scenarios. Product choices, application contexts, end-user constraints, and distribution channels further determine feasibility and effectiveness. Region-specific dynamics add another layer of complexity, requiring adaptable offerings that respect regulatory diversity and technical capacity.

For leaders seeking to strengthen their Legionella programs, the path forward combines methodological rigor, resilient procurement, workforce capability, and data-driven governance. By aligning investments with operational needs and emphasizing validated equivalence and supplier continuity, organizations can translate diagnostic advances into sustained reductions in exposure risk and improved public health outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Legionella Testing Market, by Product Type

  • 8.1. Equipment
    • 8.1.1. Automated Systems
    • 8.1.2. Manual Systems
  • 8.2. Kits
  • 8.3. Reagents And Consumables
    • 8.3.1. Antibodies
    • 8.3.2. Culture Media
    • 8.3.3. Dna Polymerases
  • 8.4. Services

9. Legionella Testing Market, by Test Method

  • 9.1. Biosensor
  • 9.2. Culture Method
    • 9.2.1. Membrane Filtration Culture
    • 9.2.2. Traditional Agar Culture
  • 9.3. Immunoassay
    • 9.3.1. Elisa
    • 9.3.2. Lateral Flow Assay
  • 9.4. Polymerase Chain Reaction
    • 9.4.1. Real-Time PCR
    • 9.4.2. Traditional PCR

10. Legionella Testing Market, by Application

  • 10.1. Environmental Monitoring
  • 10.2. Facility Management
  • 10.3. Water Treatment

11. Legionella Testing Market, by End User

  • 11.1. Commercial Buildings
  • 11.2. Hospitals
  • 11.3. Research Institutes
  • 11.4. Water Utilities

12. Legionella Testing Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Legionella Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Legionella Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Legionella Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Legionella Testing Market

17. China Legionella Testing Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Agilent Technologies, Inc.
  • 18.7. Aquacert Ltd.
  • 18.8. Beckman Coulter, Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. bioMerieux SA
  • 18.11. Bio-Rad Laboratories, Inc.
  • 18.12. Danaher Corporation
  • 18.13. DiaSorin S.p.A.
  • 18.14. Eiken Chemical Co., Ltd.
  • 18.15. Eurofins Scientific SE
  • 18.16. Hologic, Inc.
  • 18.17. Hydrosense Ltd.
  • 18.18. IDEXX Laboratories, Inc.
  • 18.19. Luminex Corporation
  • 18.20. Merck KGaA
  • 18.21. Neogen Corporation
  • 18.22. PerkinElmer, Inc.
  • 18.23. Pro-Lab Diagnostics, Inc.
  • 18.24. Qiagen N.V.
  • 18.25. Quidel Corporation
  • 18.26. Roche Diagnostics
  • 18.27. Spartan Bioscience Inc.
  • 18.28. Takara Bio Inc.
  • 18.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LEGIONELLA TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. GCC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. GCC LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 204. GCC LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 205. GCC LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 206. GCC LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 208. GCC LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GCC LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. G7 LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 236. G7 LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 237. G7 LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 238. G7 LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 239. G7 LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 241. G7 LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. NATO LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. NATO LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 249. NATO LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 250. NATO LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. NATO LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)